Maruishi Pharmaceutical

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jun 1, 2025	Allay Therapeutics	$58.0M Series D	Lightstone Ventures, Anselm Tan	Arboretum Ventures, New Enterprise Associates (NEA), Tak Cheung, New Enterprise Associates, Brandon Capital, EDBI, IPD Capital, NEA, SGInnovate, Vertex Growth, Vertex Ventures HC

Total Raised

N/A

Valuation

N/A